- Home
- LTRY vs BMRA Comparison
LTRY vs BMRA Comparison
Compare LTRY & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- BMRA
- Stock Information
- Founded
- LTRY 2015
- BMRA 1971
- Country
- LTRY United States
- BMRA United States
- Employees
- LTRY N/A
- BMRA N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LTRY Technology
- BMRA Health Care
- Exchange
- LTRY Nasdaq
- BMRA Nasdaq
- Market Cap
- LTRY N/A
- BMRA 7.4M
- IPO Year
- LTRY N/A
- BMRA N/A
- Fundamental
- Price
- LTRY $0.49
- BMRA $0.32
- Analyst Decision
- LTRY
- BMRA
- Analyst Count
- LTRY 0
- BMRA 0
- Target Price
- LTRY N/A
- BMRA N/A
- AVG Volume (30 Days)
- LTRY 52.0K
- BMRA 68.2K
- Earning Date
- LTRY 11-29-2024
- BMRA 10-15-2024
- Dividend Yield
- LTRY N/A
- BMRA N/A
- EPS Growth
- LTRY N/A
- BMRA N/A
- EPS
- LTRY N/A
- BMRA N/A
- Revenue
- LTRY $5,723,382.00
- BMRA $5,509,000.00
- Revenue This Year
- LTRY N/A
- BMRA N/A
- Revenue Next Year
- LTRY N/A
- BMRA N/A
- P/E Ratio
- LTRY N/A
- BMRA N/A
- Revenue Growth
- LTRY 125.44
- BMRA 1.74
- 52 Week Low
- LTRY $0.50
- BMRA $0.24
- 52 Week High
- LTRY $7.01
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- LTRY 34.24
- BMRA 47.45
- Support Level
- LTRY $0.51
- BMRA $0.28
- Resistance Level
- LTRY $0.57
- BMRA $0.35
- Average True Range (ATR)
- LTRY 0.03
- BMRA 0.03
- MACD
- LTRY 0.01
- BMRA 0.00
- Stochastic Oscillator
- LTRY 0.00
- BMRA 38.50
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.